AK

Abhishek Kumar Yadav

Active Director Director DIN 09131380
DIN 09131380 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Abhishek Kumar Yadav

Data last updated:

Abhishek Kumar Yadav is a Director at Ilex Biologicals Private Limited (since 2021). The company operates in Pharma. Ilex Biologicals Private Limited reported revenue of ₹1.11 Cr (FY 2023).

DIN 09131380
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2021
Oldest Company Age 11 yrs
Largest company Ilex Biologicals Private Limited · ₹1.11 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ilex Biologicals Private Limited U33111UP2015PTC068554
Director02 Apr 20212015₹1.11 Cr (FY 2023)Active

Board colleagues of Abhishek Kumar Yadav

NameDINCompanyDesignation
Jitender Bansal03224215Ilex Biologicals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Ilex Biologicals Private Limited
Premium access

Shareholding and investment profile for Abhishek Kumar Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Kumar Yadav

Abhishek Kumar Yadav currently holds 1 directorship: Ilex Biologicals Private Limited (Director, since 02 Apr 2021, revenue ₹1.11 Cr (FY 2023)).

Abhishek Kumar Yadav was first appointed on 02 Apr 2021 as Director at Ilex Biologicals Private Limited.

The current boards of Abhishek Kumar Yadav's companies include Jitender Bansal (Ilex Biologicals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available